Make critical investment decisions using Tempus’ vast tumor organoid repository
A large Biopharma collaborator used Tempus’ patient-derived organoids to unlock a critical investment decision
Apr 16, 2024
Life Sciences
Case Study
A large Biopharma collaborator used Tempus’ patient-derived organoids to unlock a critical investment decision